call 1800 257 600 email [email protected]

Peutz-Jeghers Syndrome (PJS)

Peutz-Jeghers syndrome (PJS) is a rare genetic condition that increases the risk of developing certain types of cancer, most notably colon cancer. It is caused by an alteration in the serine/threonine kinase 11 (STK11) gene, which is a tumour suppressor. People with PJS often develop multiple benign polyps (which develop as hamartomas), as well as dark skin macules in and around the mouth, eyes, nostrils and fingers.

Familial cancer syndromes, also known as hereditary cancer syndromes, are rare conditions that cause an increased risk of cancer as the result of inherited genetic mutations in certain cancer-related genes. They can affect both adults and children, however they generally develop in people at a younger age than normal. While familial cancer syndromes are not classified as cancer, they are equally as severe and can be life-threatening as they are associated with the development of various tumours throughout the body. Having a familial cancer syndrome does not guarantee the development of cancer, however the risk of developing cancer is higher than those who do not have a familial cancer syndrome.

PJS is generally diagnosed equally among the sexes, and is often diagnosed between the ages of 10-30. However, anyone can develop this disease.

PJS is most commonly associated with the development of colorectal cancer, however it has also been linked to other types of tumours. Some examples include:

Treatment

When cancers are detected, they are staged and graded based on size, metastasis, and how the cancer cells look under the microscope. Staging and grading helps your doctors determine the best treatment for you. However, each patient with PJS will present with a unique disease behaviour, with varying tumour locations and symptoms. As such, there is no one treatment method that will work for everyone, and there is no standard staging system for this disease. Instead of staging and grading, your doctor will recommend a treatment plan based on the following factors:

  • Type of tumours present.
  • Whether the tumours are malignant (cancerous) or benign (non-cancerous).
  • Tumour location.
  • Whether or not malignant tumours have metastasised.
  • Your age.
  • General health.
  • Your treatment preferences.

Your doctor may also recommend genetic testing, which analyses your tumour DNA and can help determine which treatment has the greatest chance of success. They will then discuss the most appropriate treatment option for you.

Treatment options for tumours associated PJS may include:

  • Surgery to remove as much of the tumour(s) as possible – this will vary based on tumour location.
  • Chemotherapy.
  • Radiation therapy.
  • Clinical trials.
  • Palliative care.

Cancer Screening

Once a diagnosis of PJS has been confirmed, implementing a targeted screening plan becomes essential due to the increased risk of developing certain cancers.  The content of this plan will vary from person to person based on the genetic mutation involved, your family’s history of cancer and the types of cancers that may be present. It will also outline the routine tests you should have and how regularly you should have them.  For patients with PJS, the screening guidelines differ between children and adults.

Childhood PJS Screening Guidelines

For children with PJS, screening guidelines may include:

  • Gastroscopy at 8-10 years old. If polyps are detected, this may need to be repeated every 2-3 years.
  • Colonoscopy at 8-10 years old. If polyps are detected, this may need to be repeated every 2-3 years.
  • Video-capsule endoscopy at 8-10 years old. If polyps are detected, this may need to be repeated every 2-3 years.
  • CT and/or MRI of the small bowel at 8-10 years old. If polyps are detected, this may need to be repeated every 2-3 years.
  • Annual physical exams in girls starting at eight years old to check for signs of early puberty.
  • Annual testicular exams in boys starting at age 10.

Adulthood PJS Screening Guidelines

For adults with PJS, screening guidelines may include:

  • Gastroscopy every 2-3 years starting at 18 (if not already).
  • Colonoscopy every 2-3 years starting at 18 (if not already).
  • Video-capsule endoscopy every 2-3 years starting at 18 (if not already).
  • CT and/or MRI of the small bowel every 2-3 years starting at 18 (if not already).
  • MRI or endoscopic ultrasound of the pancreas every 1-2 years starting at 30-35 years old.
  • Annual testicular examinations in males (continued from childhood).
  • Annual pelvic examinations and pap smears in females starting at 18-20 years old.
  • Clinical breast examination every 6-12 months in females starting at age 30.
  • Annual mammograms in females starting at age 30.

Screening options for PJS may evolve as new technologies are developed and our understanding of the condition grows. It is essential to discuss your individual circumstances with your healthcare team to determine the most appropriate screening plan for you.

Risk factors

PJS is caused by a genetic mutation in the STK11 tumour suppressor gene, which acts to inhibit cell growth to prevent overproduction of cells and the development of tumours. It is an autosomal dominant disease, which means that you have a 50% chance of developing the condition if one of your parents carries the mutation.

Symptoms

The symptoms of PJS often vary by the type(s) of tumours present. General symptoms of PJS may include:

  • Dark brown skin macules in and around the mouth, eyes, nostrils and fingers.
  • Hamartomatous polyps in the gastrointestinal tract.
  • Abdominal pain and/or discomfort.
  • Changes in bowel movements, potentially including:
    • Diarrhoea.
    • Constipation.
    • Feeling of incomplete bowel movement.
    • Thin bowel stools.
    • Blood in stools.
  • Constipation.
  • Unexplained weight loss/loss of appetite.
  • Fatigue.
  • Nausea and/or vomiting.

Symptoms related to specific tumours can be found on our knowledgebase.

Not everyone with the symptoms above will have cancer, but see your general practitioner (GP) if you are concerned.

Diagnosis

If your doctor suspects you have tumours associated with PJS, they may order some of the following tests to confirm the diagnosis and refer you to a specialist for treatment. The tests required for diagnosis will often vary based on the symptoms present, and where the tumour(s) are suspected to be located.

  • Physical examination.
  • Genetic testing.
  • Pelvic examination.
  • Blood tests.
  • Imaging tests, potentially including:
    • MRI (magnetic resonance imaging).
    • CT (computed tomography) scan.
    • Ultrasound.
    • Mammogram.
  • Exploratory procedures, potentially including:
    • Colonoscopy.
    • Gastroscopy.
    • Video-capsule endoscopy.
  • Biopsy (where applicable).

Biopsy and Testicular Cancer

After conducting the previously mentioned diagnostic tests, your doctor may strongly suspect that you have a testicular cancer. In most cases, a diagnosis can be confirmed after a biopsy, where a section of tissue is removed and analysed for cancer cells. However, doctors avoid conducting a biopsy in patients who have suspected testicular cancer as there is a small risk that making an incision in the scrotum could cause cancer cells to spread.  As such, the only way to confirm the diagnosis safely is to perform a unilateral orchidectomy.

Once the testicle has been removed, it will be sent to a laboratory and analysed for cancer cells.

References

Keep up with Rare Cancers Australia

Inside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.